| 注册
首页|期刊导航|山东医药|结直肠癌围手术期患者外周血 T 淋巴细胞CD69、HLA-DR 表达变化及意义

结直肠癌围手术期患者外周血 T 淋巴细胞CD69、HLA-DR 表达变化及意义

王祥安 吴琼 虞黎明 邹镇洪 蔡磊 熊妮 杨刚

山东医药2016,Vol.56Issue(13):7-9,3.
山东医药2016,Vol.56Issue(13):7-9,3.DOI:10.3969/j.issn.1002-266X.2016.13.003

结直肠癌围手术期患者外周血 T 淋巴细胞CD69、HLA-DR 表达变化及意义

Expression and significance of CD69 and HLA-DR in T lymphocytes of peripheral blood in perioperative period of patients with colorectal cancer

王祥安 1吴琼 1虞黎明 1邹镇洪 1蔡磊 1熊妮 2杨刚1

作者信息

  • 1. 南昌大学第二附属医院,南昌330006
  • 2. 南昌大学
  • 折叠

摘要

Abstract

Objective To observe the expression changes and significance of CD69 and HLA-DR in T lymphocytes of peripheral blood in perioperative period of patients with colorectal cancer.Methods Flow eytometry was used to detect the expression of CD69 and HLA-DR in T lymphocytes of peripheral blood in 40 cases of perioperative period ( including the preoperative and postoperative 5, 10 days) of patients with colorectal cancer (observation group), and in 15 cases of healthy persons ( control group) .The relationship of their expression with clinicopathologic features was analyzed.Results The expression of CD69 and HLA-DR before surgery was significantly lower in the observation group than that of the con-trol group (P<0.05), with further increase after surgery (P<0.05).The expression of HLA-DR was related with lymph node metastasis, distant metastasis and TNM stage after surgery (P<0.05), but was not related with the rest of clinico-pathologic features (all P>0.05).Conclusions The expression of CD69 and HLA-DR before surgery in T lymphocytes of peripheral blood in the perioperative period of patients with colorectal cancer was significantly decreased, and gradually in-creased after surgery.The detection of CD69 and HLA-DR contributes to determining the state of an illness and guiding im-mune therapy for colorectal cancer.

关键词

结直肠肿瘤/围手术期/T淋巴细胞/CD69/HLA-DR

Key words

colorectal carcinoma/perioperative period/T lymphocytes/CD69/HLA-DR

分类

医药卫生

引用本文复制引用

王祥安,吴琼,虞黎明,邹镇洪,蔡磊,熊妮,杨刚..结直肠癌围手术期患者外周血 T 淋巴细胞CD69、HLA-DR 表达变化及意义[J].山东医药,2016,56(13):7-9,3.

基金项目

江西省卫生厅科技计划项目(20141081)。 ()

山东医药

OA北大核心CSTPCD

1002-266X

访问量1
|
下载量0
段落导航相关论文